Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GSK terminates MIV-210 partnership

Dec. 29, 2004

EMEA warns on coadministration of Reyataz and Norvir with omeprazole

Dec. 27, 2004

European marketing approval for Kivexa

Dec. 27, 2004

BMS and Gilead to develop fixed combination HIV medication

Dec. 22, 2004

NIAID approval for advanced preclinical testing of Mymetics' HIV vaccine

Dec. 22, 2004

New Invirase 500 mg receives FDA approval

Dec. 21, 2004

Milestone in Merck's PER.C6-related HIV program

Dec. 20, 2004

Phase IIa study of PA-457 in HIV patients

Dec. 14, 2004

Launch of Fuzeon Accelerated Simultaneous Access Program

Dec. 7, 2004

Good safety profile reported for C31G vaginal gel in healthy volunteers

Dec. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...